Shopping Cart 0
Cart Subtotal
USD 0

Washington University in St Louis - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Washington University in St Louis (WUSTL), a subsidiary of University of Washington is an educational university which provides education and research services. The university provides various courses of bachelor's, master's, and doctoral degrees in a wide range of traditional and interdisciplinary fields. It provides degree programs in the areas of law, engineering, education, business and international affairs, medicine, public health, and others. The university's schools include School of Engineering & Applied Science, Sam Fox School of Design and Visual Arts, George Warren Brown School of Social Work, and others. WUSTL is headquartered in St. Louis, Missouri, the US.

Washington University in St Louis-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University in St Louis, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University in St Louis, Medical Devices Deals, 2012 to YTD 2018 10

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Washington University in St Louis, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

Pfizer Enters into Agreement with Washington University in St. Louis 13

GenVec Enters into Agreement with Washington University in St. Louis 14

MaxCyte Enters into Agreement with Washington University in St Louis 15

Turing Pharma Enters into Partnership with Washington University 16

Johnson & Johnson Innovation Enters into Research Agreement with Washington University 17

GenVec Enters into Agreement with Washington University at St. Louis 18

Licensing Agreements 19

Q BioMed to Expand Option Agreement with Washington University 19

Disarm Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 20

Canopy Biosciences Enters into Licensing Agreement with Washington University in St. Louis and Johns Hopkins University 21

Precision Virologics Enters into Licensing Agreement with Washington University 22

Accuronix Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 23

ViewPoint Therapeutics Receives Technology Rights from University of Michigan and Washington University 24

Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 25

ChromaDex Amends Licensing Agreement With Washington University For Nicotinamide Riboside 26

Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 27

Washington University in St Louis-Key Competitors 28

Washington University in St Louis-Key Employees 29

Washington University in St Louis-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Government and Public Interest 31

Nov 01, 2018: Orion Research Foundation grants million euros for research in 2019 31

Oct 15, 2018: New child maltreatment research center launched with USD 6.5 million NIH grant 33

Oct 04, 2018: NIH funds specialized centers for child maltreatment research 34

Aug 02, 2018: Role of cell group behavior in cancer target of USD 1.9 million award 35

Jun 28, 2018: Kuehner commits USD 15 million to fund personalized medicine research 36

Jun 11, 2018: USD 14 million to fund research aimed at reducing childhood obesity 37

May 23, 2018: Foundation for Anesthesia Education and Research Awards USD 1.4 million in Grants 39

Apr 26, 2018: Noninvasive brain tumor biopsy on the horizon 42

Feb 27, 2018: Cure Alzheimer's Fund Issued more than USD 15 Million in Research Grants in 2017 44

Feb 27, 2018: Engineer develops enabling technology for emerging gene therapies 45

Nov 02, 2017: Lung Cancer Research Foundation Awards USD 1.6 Million in Research Grants 47

Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 49

Sep 25, 2017: Human antibodies from dengue patients can effectively treat Zika infection in mice 50

Sep 25, 2017: Antibody protects against both Zika and dengue, mouse study shows 52

Sep 20, 2017: Newly ID'd role of major Alzheimer's gene suggests possible therapeutic target 54

Jul 17, 2017: Top Cancer Research Facilities Nationwide Fueled With USD 1.2 Million In New Slate Of Grants 56

Apr 27, 2017: Stem cells edited to fight arthritis 57

Mar 13, 2017: University Of Utah Engineers Use CRISPR Technology To Prevent Tissue Damage And Resulting Chronic Pain 59

Clinical Trials 60

Oct 26, 2017: NIH study identifies new targets for anti-malaria drugs 60

Other Significant Developments 61

Sep 04, 2018: Focused delivery for brain cancers 61

Appendix 63

Methodology 63

About GlobalData 63

Contact Us 63

Disclaimer 63


List Of Figure

List of Figures

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University in St Louis, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Washington University in St Louis, Pharmaceuticals & Healthcare, Key Facts 2

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University in St Louis, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University in St Louis, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University in St Louis, Medical Devices Deals, 2012 to YTD 2018 10

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Pfizer Enters into Agreement with Washington University in St. Louis 13

GenVec Enters into Agreement with Washington University in St. Louis 14

MaxCyte Enters into Agreement with Washington University in St Louis 15

Turing Pharma Enters into Partnership with Washington University 16

Johnson & Johnson Innovation Enters into Research Agreement with Washington University 17

GenVec Enters into Agreement with Washington University at St. Louis 18

Q BioMed to Expand Option Agreement with Washington University 19

Disarm Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 20

Canopy Biosciences Enters into Licensing Agreement with Washington University in St. Louis and Johns Hopkins University 21

Precision Virologics Enters into Licensing Agreement with Washington University 22

Accuronix Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 23

ViewPoint Therapeutics Receives Technology Rights from University of Michigan and Washington University 24

Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 25

ChromaDex Amends Licensing Agreement With Washington University For Nicotinamide Riboside 26

Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 27

Washington University in St Louis, Key Competitors 28

Washington University in St Louis, Key Employees 29

Washington University in St Louis, Subsidiaries 30

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Washington University in St Louis, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Washington University in St Louis (WUSTL), a subsidiary of University of Washington is an educational university which provides education and research services. The university provides various courses of bachelor's, master's, and doctoral degrees in a wide range of traditional and interdisciplinary fields. It provides degree programs in the areas of law, engineering, education, business and international affairs, medicine, public health, and others. The university's schools include School of Engineering & Applied Science, Sam Fox School of Design and Visual Arts, George Warren Brown School of Social Work, and others. WUSTL is headquartered in St. Louis, Missouri, the US.

Washington University in St Louis-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University in St Louis, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University in St Louis, Medical Devices Deals, 2012 to YTD 2018 10

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Washington University in St Louis, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

Pfizer Enters into Agreement with Washington University in St. Louis 13

GenVec Enters into Agreement with Washington University in St. Louis 14

MaxCyte Enters into Agreement with Washington University in St Louis 15

Turing Pharma Enters into Partnership with Washington University 16

Johnson & Johnson Innovation Enters into Research Agreement with Washington University 17

GenVec Enters into Agreement with Washington University at St. Louis 18

Licensing Agreements 19

Q BioMed to Expand Option Agreement with Washington University 19

Disarm Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 20

Canopy Biosciences Enters into Licensing Agreement with Washington University in St. Louis and Johns Hopkins University 21

Precision Virologics Enters into Licensing Agreement with Washington University 22

Accuronix Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 23

ViewPoint Therapeutics Receives Technology Rights from University of Michigan and Washington University 24

Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 25

ChromaDex Amends Licensing Agreement With Washington University For Nicotinamide Riboside 26

Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 27

Washington University in St Louis-Key Competitors 28

Washington University in St Louis-Key Employees 29

Washington University in St Louis-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Government and Public Interest 31

Nov 01, 2018: Orion Research Foundation grants million euros for research in 2019 31

Oct 15, 2018: New child maltreatment research center launched with USD 6.5 million NIH grant 33

Oct 04, 2018: NIH funds specialized centers for child maltreatment research 34

Aug 02, 2018: Role of cell group behavior in cancer target of USD 1.9 million award 35

Jun 28, 2018: Kuehner commits USD 15 million to fund personalized medicine research 36

Jun 11, 2018: USD 14 million to fund research aimed at reducing childhood obesity 37

May 23, 2018: Foundation for Anesthesia Education and Research Awards USD 1.4 million in Grants 39

Apr 26, 2018: Noninvasive brain tumor biopsy on the horizon 42

Feb 27, 2018: Cure Alzheimer's Fund Issued more than USD 15 Million in Research Grants in 2017 44

Feb 27, 2018: Engineer develops enabling technology for emerging gene therapies 45

Nov 02, 2017: Lung Cancer Research Foundation Awards USD 1.6 Million in Research Grants 47

Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 49

Sep 25, 2017: Human antibodies from dengue patients can effectively treat Zika infection in mice 50

Sep 25, 2017: Antibody protects against both Zika and dengue, mouse study shows 52

Sep 20, 2017: Newly ID'd role of major Alzheimer's gene suggests possible therapeutic target 54

Jul 17, 2017: Top Cancer Research Facilities Nationwide Fueled With USD 1.2 Million In New Slate Of Grants 56

Apr 27, 2017: Stem cells edited to fight arthritis 57

Mar 13, 2017: University Of Utah Engineers Use CRISPR Technology To Prevent Tissue Damage And Resulting Chronic Pain 59

Clinical Trials 60

Oct 26, 2017: NIH study identifies new targets for anti-malaria drugs 60

Other Significant Developments 61

Sep 04, 2018: Focused delivery for brain cancers 61

Appendix 63

Methodology 63

About GlobalData 63

Contact Us 63

Disclaimer 63


List Of Figure

List of Figures

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University in St Louis, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Washington University in St Louis, Pharmaceuticals & Healthcare, Key Facts 2

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University in St Louis, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University in St Louis, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University in St Louis, Medical Devices Deals, 2012 to YTD 2018 10

Washington University in St Louis, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Pfizer Enters into Agreement with Washington University in St. Louis 13

GenVec Enters into Agreement with Washington University in St. Louis 14

MaxCyte Enters into Agreement with Washington University in St Louis 15

Turing Pharma Enters into Partnership with Washington University 16

Johnson & Johnson Innovation Enters into Research Agreement with Washington University 17

GenVec Enters into Agreement with Washington University at St. Louis 18

Q BioMed to Expand Option Agreement with Washington University 19

Disarm Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 20

Canopy Biosciences Enters into Licensing Agreement with Washington University in St. Louis and Johns Hopkins University 21

Precision Virologics Enters into Licensing Agreement with Washington University 22

Accuronix Therapeutics Enters into Licensing Agreement with Washington University in St. Louis 23

ViewPoint Therapeutics Receives Technology Rights from University of Michigan and Washington University 24

Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 25

ChromaDex Amends Licensing Agreement With Washington University For Nicotinamide Riboside 26

Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 27

Washington University in St Louis, Key Competitors 28

Washington University in St Louis, Key Employees 29

Washington University in St Louis, Subsidiaries 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Washington University in St Louis, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.